Skip to search formSkip to main contentSkip to account menu

BV Regimen

Known as: Bleomycin-Vincristine Regimen 
A regimen consisting of bleomycin and vincristine used for the treatment of Kaposi's Sarcoma.
National Institutes of Health

Related topics

Related topics

3 relations
AIDS with Kaposi's sarcomaBleomycinVincristine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Novel Therapy for Aggressive Cutaneous T-Cell Lymphoma Leading to Complete Clinical Remission before Allogenic Stem Cell Transplantation
Cutaneous T-cell lymphomas (CTCL) represent up to 80% of extranodal non-Hodgkin Lymphomas, the most common being Mycosis… 
2014
2014
Retrospective analysis on the efficacy of bevacizumab with FOLFOX as a first‐line treatment in Japanese patients with metastatic colorectal cancer
Past reports have suggested that the addition of bevacizumab (BV) to oxaliplatin combined with 5‐fluorouracil (5‐FU) and folinic… 
2011
2011
Bevacizumab (BV) continuation following BV progression: Meta-analysis of five consecutive recurrent glioblastoma (GBM) trials.
2030 Background: Although BV benefits most recurrent GBM patients, the duration of benefit is limited and subsequent survival… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)